R. Wijsman

J. Bussink, J. Kaanders, R. Wijsman, 2013, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy.

L. de Geus-Oei, J. Bussink, R. Monshouwer, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Factors influencing the activity and fate of benzodiazepines in the body.

T. Vree, R. Wijsman, A. M. Baars, 1981, British journal of clinical pharmacology.

Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial.

H. Groen, B. Hiddinga, R. Wijsman, 2023, Lung cancer.

Deep Learning Model for Automatic Contouring of Cardiovascular Substructures on Radiotherapy Planning CT Images: Dosimetric Validation and Reader Study based Clinical Acceptability Testing.

J. Bussink, R. Monshouwer, J. Teuwen, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring 18F-FDG-PET/CT

J. Bussink, O. Schuurbiers, R. Wijsman, 2018, Physics and imaging in radiation oncology.

The REACT-Study - a Comprehensive Data Set of REpeated 4D CTs and Cbcts to Prepare for Pencil Beam Scanned Proton Therapy (PBS-PT) in Lung and Esophagus Patients

J. Langendijk, A. Knopf, S. Both, 2019, International Journal of Radiation Oncology*Biology*Physics.

Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers

Timothy Solberg, Issam El Naqa, Gilmer Valdes, 2018, Medical physics.

Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patients

L. de Geus-Oei, E. Visser, J. Bussink, 2015, Nuclear medicine communications.

Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations.

D. de Ruysscher, R. Wijsman, L. Hendriks, 2023, European journal of cancer.

Clinical 3D/4D cumulative proton dose assessment methods for thoracic tumours with large motion.

J. Langendijk, S. Both, E. Korevaar, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Towards the clinical implementation of intensity-modulated proton therapy for thoracic indications with moderate motion: Robust optimised plan evaluation by means of patient and machine specific information.

J. Langendijk, A. Knopf, N. Sijtsema, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy: results on local control and survival.

J. Langendijk, J. Maduro, G. D. de Bock, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.

Esther G C Troost, Robin Wijsman, Johan Bussink, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Esophageal wall dose-surface maps do not improve the predictive performance of a multivariable NTCP model for acute esophageal toxicity in advanced stage NSCLC patients treated with intensity-modulated (chemo-)radiotherapy

J. Bussink, R. Monshouwer, A. Hoffmann, 2017, Physics in medicine and biology.

Inter- and intrafractional 4D dose accumulation for evaluating ΔNTCP robustness in lung cancer.

T. Lomax, J. Langendijk, D. Weber, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Survival prediction for stage I-IIIA non-small cell lung cancer using deep learning.

M. Oudkerk, J. Langendijk, N. Sijtsema, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Updating Photon-based Normal Tissue Complication Probability Models for Pneumonitis in Lung Cancer Patients Treated with Proton Beam Therapy.

A. van der Schaaf, C. Simone, K. Cengel, 2020, Practical radiation oncology.

The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.

E. Dieleman, N. C. van der Voort van Zyp, J. Pomp, 2022, Clinical lung cancer.

Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy: results on local control and survival.

J. Langendijk, J. Maduro, G. D. de Bock, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy.

Robin Wijsman, Johan Bussink, Frank Dankers, 2017, International journal of radiation oncology, biology, physics.

Estimating how contouring differences affect normal tissue complication probability modelling

B. Stam, R. Wijsman, René Monshouwer, 2024, Physics and imaging in radiation oncology.